Background: Semaglutide is a GLP-1 receptor agonist used as a therapy to improve glycemic control in patients with Type 2 Diabetes Mellitus. Although its use continues to increase globally, data regarding the utilization pattern of this drug in Indonesia, remains scarce. Objective: To determine the pattern of semaglutide use among T2DM patients at Siloam Sriwijaya Hospital Palembang from Januar…